• Blog
  • Point Of Care Coagulation Testing Market Report

    Point Of Care Coagulation Testing Market Report

    Point Of Care Coagulation Testing Market Report
    Report code - SRHL278 Delivery - 2 Weeks
    Get Free Sample |
    Play Audio
    Listen
    Global Point-of-Care Coagulation Testing Market, Dynamics, and Market Analysis
    See more...

    Impact of COVID-19 on Point Of Care Coagulation Testing Market

    Covid-19 has impacted the market dynamics, competition, and global...

    See more...

    Impact of COVID-19 on Point Of Care Coagulation Testing Market

    Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.

    Note: The summary below might not have included insights on covid impact since we have large number of reports.

    Market Insights

    The Global Point-of-Care Coagulation Testing Market is expected to grow from USD xx billion in 2020 to USD xx billion by 2026 at a CAGR of over x% during the forecast period.

    Figure: Global Point-of-Care Coagulation Testing Market Size, 2020-2026 (USD Billion)

    Point-of-Care-Coagulation-Testing-Market-Forecast

    To know about the assumptions related to the report, Request for Free Sample here.

    What is Point-of-Care Coagulation Testing?

    A point-of-care coagulation test is used to monitor anticoagulation to prevent severe adverse reactions which may result in critical conditions like thrombosis or haemorrhage. The instruments used for point of care coagulation testing are lower end and less complex designed as a backup for the central coagulation laboratory or physician office laboratories.

    Key Players

    Key players operating in the global Point-of-Care Coagulation Testing Market are-

    • Abbott Laboratories (The U.S),
    • Danaher Corporation (The U.S),
    • Diagnostica Stago SAS (France),
    • F. Hoffmann-La Roche AG (Switzerland),
    • Helena Laboratories Corporation (The U.S),
    • iLine Microsystems SL (Spain)
    • Medtronic Plc (The U.S),
    • Micropoint Bioscience Inc. (The U.S),
    • Siemens Healthineers AG (Germany), and
    • Sysmex Corporation (Japan).

    Market Dynamics

    Growing emphasis on the development of advanced point of care coagulation testing which is easy to handle and operate is likely to create significant growth opportunities for the market players.

    • The growth of the global Point-of-care coagulation testing market is primarily driven by an increasing number of patients having bleeding disorders such as von Willebrand, venous thromboembolism, and haemophilia.
    • Changing haemostatic balance in the people with increasing age is likely to propel the market growth at a significant rate across geographies during the review period.
    • However, the high cost of point-of-care coagulation testing is likely to hamper the market growth.

    Segment Analysis

    Type Trends

    Based on end user, the market has been segmented into hospitals and private clinics and homecare.

    The hospitals & private clinics segment accounted for the largest market share in 2020 due to its availability of skilled staff and necessary infrastructure. The homecare segment is projected to register healthy growth during the review period due to increasing healthcare costs.   

    Regional Trends

    Geographically, the market in North America accounted for the largest market share of around 40% in 2020 and is projected to continue its dominance during the review period.

    • The regional market growth can be attributed to expanding geriatric population and presence of key market players such as Abbott Laboratories (The U.S), and Danaher Corporation (The U.S).
    • The market in Asia-Pacific is expected to grow at a fastest CAGR during the review period on account of increasing healthcare costs and rising awareness regarding monitoring of bleeding disorders.

    COVID-19 Impact on Global Point-of-Care Coagulation Testing Market

    The covid-19 outbreak affected the growth of the Point-of-care coagulation testing market short period of time as due to supply chain disruptions amid lockdown; the product availability in the market was hampered. Additionally, according to studies, the Covid-19 patients were at high risk of developing venous blood clots and other complications related to blood clotting, which, in turn, has driven the demand for point of care coagulation testing.

    Critical Questions Answered in the Report

    • What are the key trends in the global Point-of-care coagulation testing market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the global Point-of-care coagulation testing market?
    • What are the key strategies adopted by the major vendors to lead in the global Point-of-care coagulation testing market?
    • What is the market share of the top vendors?

    Wish to learn more about this report? Request a sample here.

    Target Audience

    The following is a list of the customers that the Global point-of-care coagulation testing market aims to convert the most:

    • Point-of-care coagulation testing manufacturers
    • Point-of-care coagulation testing suppliers
    • Point-of-care coagulation testing distributors
    • Organizations
    • Government bodies

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].

    Frequently Asked Questions (FAQs)

    Abbott Laboratories (The U.S), Danaher Corporation (The U.S), Diagnostica Stago SAS (France), F. Hoffmann-La Roche AG (Switzerland), Helena Laboratories Corporation (The U.S), iLine Microsystems SL (Spain), Medtronic Plc (The U.S), Micropoint Bioscience Inc. (The U.S), Siemens Healthineers AG (Germany) and Sysmex Corporation (Japan) are among the key players in the point-of-care coagulation tasting market.

    North America accounted for the largest share of point-of-care coagulation testing market in 2020.

    Asia-pacific is expected to grow at the fastest CAGR in the point-of-care coagulation testing market during the forecast period.

    Growing emphasis on the development of advanced point of care coagulation testing, increasing number of patients having bleeding disorders, changing haemostatic balance in the people with increasing age are the factors driving the growth of point-of-care coagulation testing market.

    The hospitals & private clinics segment accounted for the largest share in the point-of-care coagulation testing market in 2020.

    Point-of-care coagulation testing manufacturers, Point-of-care coagulation testing suppliers, Point-of-care coagulation testing distributors, Organizations, Government bodies are the target audience in the point-of-care coagulation testing market.

    •